We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$6.99B
AUM Growth
+$1.23B
Cap. Flow
-$140M
Cap. Flow %
-2%
Top 10 Hldgs %
22.95%
Holding
1,634
New
85
Increased
643
Reduced
463
Closed
238

Top Buys

Rank Stock Value
1
DBRG icon
DigitalBridge
DBRG
+$21.6M
2
GDS icon
GDS Holdings
GDS
+$16.6M
3
DELL icon
Dell
DELL
+$12.3M
4
PARA
Paramount Global Class B
PARA
+$12M
5
LUMN icon
Lumen
LUMN
+$11M

Sector Composition

Rank Sector Weight
1 Real Estate 16.24%
2 Technology 13.67%
3 Consumer Discretionary 10.4%
4 Healthcare 8.54%
5 Communication Services 6.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRX
1276
DELISTED
Catalyst Pharmaceutical
CPRX
-10,206
Closed -$47K
CRIS icon
1277
Curis
CRIS
$9.53M
-11
Closed -$49K
CTMX icon
1278
CytomX Therapeutics
CTMX
$705M
-3,806
Closed -$29K
CUE icon
1279
Cue Biopharma
CUE
$135M
-51
Closed -$19K
CVM icon
1280
CEL-SCI Corp
CVM
$20.6M
-113
Closed -$51K
CYTK icon
1281
Cytokinetics
CYTK
$11B
-3,417
Closed -$79K
DNLI icon
1282
Denali Therapeutics
DNLI
$3.67B
-1,204
Closed -$69K
DTIL icon
1283
Precision BioSciences
DTIL
$188M
-221
Closed -$69K
DVAX
1284
DELISTED
Dynavax Technologies
DVAX
-8,133
Closed -$80K
EDIT icon
1285
Editas Medicine
EDIT
$399M
-1,682
Closed -$71K
EEM icon
1286
iShares MSCI Emerging Markets ETF
EEM
$28.5B
-2,680
Closed -$143K
ENTA icon
1287
Enanta Pharmaceuticals
ENTA
$372M
-798
Closed -$39K
ESPR
1288
DELISTED
Esperion Therapeutics
ESPR
-2,572
Closed -$72K
EWY icon
1289
iShares MSCI South Korea ETF
EWY
$22.7B
-86,514
Closed -$7.76M
FATE icon
1290
Fate Therapeutics
FATE
$281M
-822
Closed -$68K
KYNB
1291
Kyntra Bio
KYNB
$28.5M
-88
Closed -$77K
FHI icon
1292
Federated Hermes
FHI
$4.4B
-10,034
Closed -$314K
FOLD
1293
DELISTED
Amicus Therapeutics
FOLD
-7,238
Closed -$72K
GBIO
1294
DELISTED
Generation Bio
GBIO
-224
Closed -$64K
GCOW icon
1295
Pacer Global Cash Cows Dividend ETF
GCOW
$3.33B
-9,798
Closed -$301K
GES
1296
DELISTED
Guess Inc
GES
-120,697
Closed -$2.84M
GERN icon
1297
Geron
GERN
$911M
-18,114
Closed -$29K
GMS
1298
DELISTED
GMS Inc
GMS
-58,652
Closed -$2.45M
GNW icon
1299
Genworth Financial
GNW
$3.8B
-53,954
Closed -$179K
GOSS icon
1300
Gossamer Bio
GOSS
$66.5M
-4,059
Closed -$38K

Similar funds

Pacer Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Pacer Advisors held 1,634 positions worth $6.99B, up 21% from $5.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Pacer Advisors's Q2 2021 filing shows 85 new, 643 increased, 463 reduced and 238 closed positions. Its largest new stake was DigitalBridge: 754,679 shares worth $23.8M. The largest sale was Crown Castle, an estimated $11.5M.

By sector, the portfolio is most concentrated in Real Estate at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Pacer Advisors's largest Q2 2021 buy was DigitalBridge: 754,679 shares worth $23.8M.
  • Pacer Advisors added most to GDS Holdings in Q2 2021, an estimated $16.6M increase.
  • Pacer Advisors's biggest Q2 2021 reduction was Crown Castle, cutting an estimated $11.5M.
  • Pacer Advisors fully exited Pacer Trendpilot US Mid Cap ETF in Q2 2021, selling an estimated $8.38M.
  • Pacer Advisors's ten largest holdings make up 23% of its $6.99B portfolio in Q2 2021.
  • Pacer Advisors opened 85 new positions and closed 238 in Q2 2021.
  • Pacer Advisors's portfolio value rose 21% quarter-over-quarter to $6.99B.

Based on Pacer Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.